# Carver Bancorp Inc: financial statements, quarterly

CARV · OTC · CIK 1016178 · [Financials](/sectors/financials.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/carv.md) · [Financials](/companies/carv/financials.md) · [Filings](/companies/carv/filings.md) · [Insiders](/companies/carv/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/carv/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2022-12-31) | Q4 FY2023 (2023-03-31) | Q1 FY2024 (2023-06-30) | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [671](/filings/0001016178-24-000005.md) | [710 d](/filings/0001016178-24-000013.md) | [686](/filings/0001016178-24-000020.md) | [767](/filings/0001016178-24-000026.md) | [731](/filings/0001016178-25-000005.md) | [774 d](/filings/0001016178-25-000010.md) | [578](/filings/0001016178-25-000015.md) | [711](/filings/0001016178-25-000021.md) | [953](/filings/0001016178-25-000005.md) | [762 d](/filings/0001016178-25-000010.md) | [964](/filings/0001016178-25-000015.md) | [1,206](/filings/0001016178-25-000021.md) |
| Operating income | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $k | [1,455](/filings/0001016178-24-000005.md) | [1,675 d](/filings/0001016178-24-000013.md) | [2,292](/filings/0001016178-24-000020.md) | [2,611](/filings/0001016178-23-000022.md) | [2,993](/filings/0001016178-24-000005.md) | [3,562 d](/filings/0001016178-24-000013.md) | [3,703](/filings/0001016178-24-000020.md) | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | [0.0](/filings/0001016178-24-000005.md) | [0.0 d](/filings/0001016178-24-000013.md) | [0.0](/filings/0001016178-24-000020.md) | [0.0](/filings/0001016178-24-000026.md) | [0.0](/filings/0001016178-25-000005.md) | [0.0 d](/filings/0001016178-25-000010.md) | [0.0](/filings/0001016178-25-000015.md) | [0.0](/filings/0001016178-25-000021.md) | [0.0](/filings/0001016178-25-000005.md) | [0.0 d](/filings/0001016178-25-000010.md) | [0.0](/filings/0001016178-25-000015.md) | [0.0](/filings/0001016178-25-000021.md) |
| Net income | $k | [(1,089)](/filings/0001016178-24-000005.md) | [(1,500) d](/filings/0001016178-24-000013.md) | [(1,421)](/filings/0001016178-24-000020.md) | [(1,586)](/filings/0001016178-24-000026.md) | [19.0](/filings/0001016178-25-000005.md) | [11.0 d](/filings/0001016178-25-000010.md) | [(2,212)](/filings/0001016178-25-000015.md) | [(2,113)](/filings/0001016178-25-000021.md) | [(5,648)](/filings/0001016178-25-000005.md) | [(3,771) d](/filings/0001016178-25-000010.md) | [(1,177)](/filings/0001016178-25-000015.md) | [(2,431)](/filings/0001016178-25-000021.md) |
| Diluted EPS | $ per share | [(0.25)](/filings/0001016178-24-000005.md) | not reported | [(0.32)](/filings/0001016178-24-000020.md) | [(0.33)](/filings/0001016178-24-000026.md) | [0.00](/filings/0001016178-25-000005.md) | not reported | [(0.43)](/filings/0001016178-25-000015.md) | [(0.41)](/filings/0001016178-25-000021.md) | [(1.09)](/filings/0001016178-25-000005.md) | not reported | [(0.22)](/filings/0001016178-25-000015.md) | [(0.46)](/filings/0001016178-25-000021.md) |
| Basic EPS | $ per share | [(0.25)](/filings/0001016178-24-000005.md) | not reported | [(0.32)](/filings/0001016178-24-000020.md) | [(0.33)](/filings/0001016178-24-000026.md) | [0.00](/filings/0001016178-25-000005.md) | not reported | [(0.43)](/filings/0001016178-25-000015.md) | [(0.41)](/filings/0001016178-25-000021.md) | [(1.09)](/filings/0001016178-25-000005.md) | not reported | [(0.22)](/filings/0001016178-25-000015.md) | [(0.46)](/filings/0001016178-25-000021.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2022-12-31) | FY2023 (2023-03-31) | Q1 FY2024 (2023-06-30) | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [43.9](/filings/0001016178-23-000006.md) | [42.6](/filings/0001016178-24-000013.md) | [41.7](/filings/0001016178-23-000017.md) | [52.2](/filings/0001016178-23-000022.md) | [75.2](/filings/0001016178-24-000005.md) | [59.0](/filings/0001016178-25-000010.md) | [46.3](/filings/0001016178-24-000020.md) | [54.5](/filings/0001016178-24-000026.md) | [50.0](/filings/0001016178-25-000005.md) | [50.3](/filings/0001016178-25-000021.md) | [43.8](/filings/0001016178-25-000015.md) | [40.7](/filings/0001016178-25-000021.md) |
| Total assets | $m | [712](/filings/0001016178-23-000006.md) | [723](/filings/0001016178-24-000013.md) | [712](/filings/0001016178-23-000017.md) | [743](/filings/0001016178-23-000022.md) | [775](/filings/0001016178-24-000005.md) | [757](/filings/0001016178-25-000010.md) | [747](/filings/0001016178-24-000020.md) | [749](/filings/0001016178-24-000026.md) | [728](/filings/0001016178-25-000005.md) | [730](/filings/0001016178-25-000021.md) | [714](/filings/0001016178-25-000015.md) | [698](/filings/0001016178-25-000021.md) |
| Total liabilities | $m | [667](/filings/0001016178-23-000006.md) | [678](/filings/0001016178-24-000013.md) | [669](/filings/0001016178-23-000017.md) | [703](/filings/0001016178-23-000022.md) | [733](/filings/0001016178-24-000005.md) | [714](/filings/0001016178-25-000010.md) | [707](/filings/0001016178-24-000020.md) | [709](/filings/0001016178-24-000026.md) | [695](/filings/0001016178-25-000005.md) | [700](/filings/0001016178-25-000021.md) | [685](/filings/0001016178-25-000015.md) | [671](/filings/0001016178-25-000021.md) |
| Long-term debt | $m | not reported | [40.9](/filings/0001016178-23-000011.md) | not reported | not reported | not reported | [46.4](/filings/0001016178-24-000013.md) | not reported | not reported | not reported | [20.2](/filings/0001016178-25-000010.md) | not reported | not reported |
| Shareholders' equity | $m | [45.1](/filings/0001016178-24-000005.md) | [45.2](/filings/0001016178-25-000010.md) | [42.5](/filings/0001016178-24-000026.md) | [39.7](/filings/0001016178-25-000005.md) | [42.7](/filings/0001016178-25-000005.md) | [42.3](/filings/0001016178-25-000021.md) | [39.9](/filings/0001016178-25-000021.md) | [39.9](/filings/0001016178-25-000021.md) | [32.3](/filings/0001016178-25-000005.md) | [29.6](/filings/0001016178-25-000021.md) | [28.5](/filings/0001016178-25-000021.md) | [26.9](/filings/0001016178-25-000021.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2022-12-31) | Q4 FY2023 (2023-03-31) | Q1 FY2024 (2023-06-30) | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [1,011 d](/filings/0001016178-24-000005.md) | [(1,666) d](/filings/0001016178-24-000013.md) | [(1,709)](/filings/0001016178-24-000020.md) | [(5,306) d](/filings/0001016178-24-000026.md) | [3,301 d](/filings/0001016178-25-000005.md) | [(2,857) d](/filings/0001016178-25-000010.md) | [(2,349)](/filings/0001016178-25-000015.md) | [(3,027) d](/filings/0001016178-25-000021.md) | [(1,045) d](/filings/0001016178-25-000005.md) | [(6,188) d](/filings/0001016178-25-000010.md) | [(230)](/filings/0001016178-25-000015.md) | [(1,585) d](/filings/0001016178-25-000021.md) |
| Capital expenditure | $k | [45.0 d](/filings/0001016178-24-000005.md) | [57.0 d](/filings/0001016178-24-000013.md) | [66.0](/filings/0001016178-24-000020.md) | [99.0 d](/filings/0001016178-24-000026.md) | [71.0 d](/filings/0001016178-25-000005.md) | [124 d](/filings/0001016178-25-000010.md) | [154](/filings/0001016178-25-000015.md) | [106 d](/filings/0001016178-25-000021.md) | [53.0 d](/filings/0001016178-25-000005.md) | [18.0 d](/filings/0001016178-25-000010.md) | [168](/filings/0001016178-25-000015.md) | [116 d](/filings/0001016178-25-000021.md) |
| Dividends paid | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2021-12-31) | Q1 FY2023 (2022-06-30) | Q2 FY2023 (2022-09-30) | Q3 FY2023 (2022-12-31) | Q1 FY2024 (2023-06-30) | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [5,451](/filings/0001016178-23-000006.md) | [4,229](/filings/0001016178-23-000017.md) | [4,292](/filings/0001016178-23-000022.md) | [4,295](/filings/0001016178-24-000005.md) | [4,497](/filings/0001016178-24-000020.md) | [4,816](/filings/0001016178-24-000026.md) | [6,420](/filings/0001016178-25-000005.md) | [5,141](/filings/0001016178-25-000015.md) | [5,141](/filings/0001016178-25-000021.md) | [5,189](/filings/0001016178-25-000005.md) | [5,284](/filings/0001016178-25-000015.md) | [5,287](/filings/0001016178-25-000021.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 5,095,254 at 2025-11-12, from the cover of the [10-Q filed 2025-11-13](/filings/0001016178-25-000021.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:30 ET. No prices; not investment advice.